ZS Pharma (ZSPH) Misses Q1 EPS by 19c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. JNJ
5. MSFT
6. PLTR
7. QQQ
8. LDOS
9. AXP
10. AON

Go back to ZS Pharma (ZSPH) Misses Q1 EPS by 19c

ZS Pharma Reports First Quarter 2015 Financial Results and Provides ZS-9 Program Update

May 11, 2015 4:01 PM EDT

REDWOOD CITY, Calif., May 11, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq: ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic disorders, today provided a program update on ZS-9 (sodium zirconium cyclosilicate), the Company's investigational treatment for hyperkalemia, and reported its financial results for the first quarter ended March 31, 2015.

"We remain on track to submit our NDA this quarter and our MAA in the second half of 2015 and we look forward to achieving those two important milestones," said Robert... More